normal maintenance diet containing 15.8% protein, 3.1% lipid, and 60.1% carbohydrate, of which 44.4% is starch and 2.3% total sugars (Panlab D04 diet; Panlab, Cornella, Spain). On the morning the rats were euthanized, they were food deprived for 1 h before being anesthetized (60 mg/kg sodium pentobarbital, ip) and euthanized.
Liver sampling and serum biochemistry
Blood was collected from the inferior cava vein; serum was used for routine biochemistry. In addition, serum insulin (Diagnostic Products, Los Angeles, CA) and leptin (Linco Research, St. Charles, MO) concentrations were determined by ELISA. Insulin resistance was calculated by the homeostasis model assessment (HOMA) index ( 21 ) . Livers were quickly removed, weighed, and used for histology and lipid analysis.
Liver histology and lipid quantifi cation
Formalin-fi xed, paraffi n-embedded liver sections (5 m thick) were stained with hematoxylin and eosin and examined by an experienced pathologist blinded to the animal groups. Hepatic steatosis was defi ned as the percentage of hepatocytes containing macrovesicular fat droplets. The steatosis degree was evaluated in 10 randomly chosen fi elds (20× magnifi cation) from each liver specimen and graded as follows: grade 0 (<5% of hepatocytes affected), grade 1 (5-32% of hepatocytes affected), grade 2 (33-66% of hepatocytes affected), or grade 3 (>66% of hepatocytes affected). For lipid quantifi cation, livers (0.5 g) were homogenized in 10 mM PBS (4 ml), lipids were exhaustively extracted from homogenates, and lipid classes quantifi ed as detailed elsewhere ( 22 ) .
Isolation of hepatocytes and cellular RNA
Rat hepatocytes were isolated as previously described ( 23 ) and used immediately for transcriptomics or functional studies. The hepatocyte suspensions had >80% viability and were >99% nonparenchymal cell free. Total RNA was extracted from 10 × 10 6 hepatocytes using TRIzol (Invitrogen, Carlsbad, CA) purifi ed (RNeasy kit; Qiagen, Hilden, Germany), DNase I treated (Invitrogen, Carlsbad, CA), and repurifi ed according to the manufacturers' instructions. The integrity, purity, and quantity of RNA were assessed as recommended by Affymetrix (Santa Clara, CA).
Microarray hybridization and data mining
Gene expression analysis was performed by Progenika Biopharma (Derio, Spain) using the Affymetrix GeneChip® Rat Genome U34A Set and platform. Equal RNA amounts from each hepatocyte isolation from four animals of the same subgroup were pooled and used to synthesize cDNA (Invitrogen). Three independent cDNAs were generated, which were used for both microarray and quantitative PCR analyses. Biotinylated cRNAs were transcribed from cDNA templates and handled with strict adherence to the labeling, fragmentation, and hybridization protocols provided by Affymetrix. Signal and change calls were computed with statistical algorithms included in Affymetrix MAS 5.0 software and the parametric Welch t -test (GeneSpring; Silicon Genetics, Redwood City, CA). Files including a further description of the methodology, according to MIAME guidelines, and average differences and detection call values for all 24,000 sequences on chips are deposited in ArrayExpress repository under accession number E-MEXP-1414.
The functional profi les of extracted genes were analyzed by the NetAffx™ Analysis Center ( http://www.netaffx.com/ ), sis nor activate LPL to the same extent in insulin-resistant states as it does in healthy patients ( 12, 13 ) . Hence, hepatic fat accumulation occurs when increased delivery of NEFA and TG-rich lipoproteins accompanies increased hepatic FA synthesis ( 14 ) . NAFLD is also associated with hypertriglyceridemia, mainly from the overproduction of large, TG-rich VLDL ( 15 ) . This effect may be due, in part, by hepatic insulin resistance (IR) ( 16 ) , but the mechanisms involved are not completely understood, and a more comprehensive examination of the fat-insulted hepatocyte is desirable.
Although recent fi ndings implicate enhanced mitochondrial cholesterol content in the development of nonalcoholic steatohepatitis (NASH) ( 17 ) , dysregulation of ChE homeostasis in fatty liver is much less understood. In this regard, hepatocyte ChE metabolism is driven by bile acid demand, transport, and catalytic proteins that facilitate lipoprotein uptake, cholesterol synthesis, and esterification with a long-chain FA (input) as well as ChE hydrolysis and export as VLDL (output). Upstream, complex integrated networks of proteolysis-or ligand-activated transcription factors play critical roles in maintaining fuel and FA and sterol lipid homeostasis ( 18, 19 ) .
Molecular information on NAFLD would be biased if the total liver is examined, as the hepatocytes account for ‫ف‬ 80% of liver volume, while nonparenchymal cells make up ‫ف‬ 40% of the total cellularity. Similar inaccuracies would occur if only a liver biopsy sample is examined, as it represents ‫ف‬ 1:50,000 of total liver mass. To overcome these potential pitfalls, we identifi ed transcriptomic abnormalities in isolated primary hepatocytes from obese Zucker rats and their lean littermate controls. Obese, insulin-resistant Zucker rats develop early hepatic steatosis but do not spontaneously progress to steatohepatitis ( 20 ) , thus providing a good model for the study of mechanisms underlying the "fi rst hit." An additional aim of this work was to identify novel genes that may explain why fatty livers are more vulnerable to a challenging "second hit." We have identifi ed a set of 108 genes that discriminates hepatocytes from mild-to-severe steatotic livers from controls and have observed that early activation of the lipogenic program, lipogenesis, and TG-rich VLDL export occurs in-tandem with downregulation of tissue structure, steroid metabolism, detoxifi cation, and cell growth and proliferation genes. Our results strongly support the concept that aberrations in the steatotic hepatocyte extend beyond lipid accumulation.
MATERIALS AND METHODS

Animals
Animal procedures were approved by the University of the Basque Country Ethical Committee. Male Zucker fa/fa obese rats of 6, 9, and 12 weeks of age (ZO6, ZO9, and ZO12: 12, 12, and 16 rats, respectively) and age-matched lean controls (ZL6, ZL9, and ZL12: 12, 12, and 16 rats, respectively) were used (Charles River, Barcelona, Spain). Separate animal subgroups (n = 4-8/subgroup) were used for liver morphology and lipid analysis; gene expression profi ling and lipogenesis analysis; and hepatic lipoprotein production. Animals were fed ad libitum by guest, on August 28, 2017 www.jlr.org mined by the ⌬ ⌬ C T method. Normalization was performed using the Visual Basic Application GeNorm ( 26 ) . According to GeNorm, 18S rRNA and cyclophilin were suitable genes for normalization for these studies.
Determination of lipogenic enzyme activity
The cytosol of hepatocytes (30 × 10 6 ) was used to assess glucose 6-phosphate dehydrogenase ( 27 ) , malic enzyme ( 28 ) , and acetyl-CoA carboxylase (ACC) ( 29 ) activity. Protein was determined by Pierce reagent using BSA as standard.
Panther Classifi cation System ( 24 ) ( www.pantherdb.org /), and FatiGO ( 25 ) (www.fatigo.org/).
Quantitative real-time PCR
Quantitative real-time PCR (qPCR) was performed for selected genes on the three independent cDNAs generated from the pooled RNA samples used for microarrays. Quantifi cation was performed with an ABI PRISM 7000HT using TaqMan Assay-onDemand probes (available upon request) (Applied Biosystems, Foster City, CA). The relative quantities of each gene were deter- Fig. 1 . Time course of hepatic steatosis in obese Zucker rats. A: Age-dependent increases of body weight (BW), liver weight (LW), and hepatic index (LW/BW in g ×100, shown in numerals). B: Hepatic concentrations of TGs and ChEs in obese Zucker rats of 6, 9, and 12 weeks (ZO6, ZO9, and ZO12; closed symbols and bars) compared with their age-matched lean controls (ZL; open symbols and bars). C: Representative H and E staining of lean (ZL12) and obese rats. Original magnifi cation: 20× . Mean ± SD from eight (A) or four (B and C) animals; * P < 0.05, ** P < 0.01, and *** P < 0.001. Table 1 . Twelve (6 weeks and 12 weeks) and 16 (9 weeks) animals were used in each obese and lean group. * P < 0.05, ** P < 0.01, and *** P < 0.001.
Determination of hepatic VLDL production
After fasting for 5 h, rats were injected ip 600 mg/kg tyloxapol (Triton WR1339; Sigma-Aldrich, St. Louis, MO) to inhibit VLDL-TG hydrolysis by LPL. After 2 h, blood was collected and VLDLs (d < 1.006 g/ml) were isolated and characterized ( 23 ) . The VLDL-TG and VLDL-apoB post-Triton accumulation in the serum serves as a measure of VLDL production rate. Lipoprotein sizing was estimated by light scattering (Zetasizer 4; Malvern Instruments, Malvern, UK).
Statistical analysis
Except for gene expression, results are reported as mean ± SD for the number of animals indicated. Differences between groups were assessed by the unpaired t -test or the Mann-Whitney U test, as appropriate. The Spearman's r test was used to evaluate correlations between mRNA levels of validated genes by qPCR, expressed as fold change compared with controls, and the percentage of steatotic hepatocytes in each group of animals studied. A P < 0.05 value was considered signifi cant. All these calculations were performed using SPSS 15.0 statistical software (SPSS, Chicago, IL).
RESULTS
Hepatic steatosis, dyslipidemia, and insulin resistance in obese Zucker rats
Hepatomegaly and the hepatic index (liver weight/ body weight in g, × 100) increased sharply from 6-9 weeks of age and then plateaued or decreased moderately ( Fig. 1A ). TG concentration peaked in ZO9 livers, it being 8-fold higher than ZO6 and 2-fold higher than ZO12, which in turn increased 2-4-fold over their respective controls ( Fig. 1B ) . Concentration of cholesteryl ester also augmented in ZO9 and ZO12 livers (5-and 2-fold) but not in ZO6. Unesterifi ed cholesterol, phospholipid, and protein concentrations were unaffected by steatosis (data not shown). Liver histology revealed variable degrees of steatosis, predominantly macrovesicular around the pericentral 
A transcriptomic view of primary hepatocytes from steatotic livers
We used Affymetrix U34AGeneChip® that contained 24,000 probe sets representing 8,799 transcripts and expressed sequence tags derived from >7,000 genes, roughly one-third of the protein coding capacity of the rat genome. A core steatosis set was defi ned as the genes scored as present in all groups that changed statistically ( P < 0.05) in the same direction in the three comparisons. Hierarchical clustering of the steatosis-linked sequences was applied using GeneSpring ( Fig. 3A ) . A clear-cut gene clustering of the test and control samples was achieved by both the Spearman and the Pearson correlation. Like for most phenotypic features ( Figs. 1 and 2 ), dendograms revealed closer differential expression patterns between 9 and 12 week groups. A set of sequences (160 upregulated and 57 downregulated; Fig. 3B ), encoding 108 proteins of known function, were identifi ed as steatosis linked. PANTHER ( 24 ) scored as zone ( Fig. 1C ) . Grade 2 steatosis was observed in the livers of 6 (ZO6: 39 ± 4% of steatotic hepatocytes) and 9 week old Zucker rats (ZO9: 55 ± 6% of steatotic hepatocytes), whereas grade 3 steatosis was seen in the livers of 12 week old Zucker rats (ZO12: 76 ± 6% of steatotic hepatocytes). There was a signifi cant difference in the percentage of steatotic hepatocytes between ZO12 and ZO9 rats ( P < 0.001) as well as between ZO9 and ZO6 rats ( P = 0.001).
Serum ALT ( Fig. 2A ), serum lipids ( Fig. 2B ) , and serum leptin increased with body weight gain (normal values in Table 1 ). Notably, the rise in serum TG was greater than that of total cholesterol and HDL cholesterol ( Fig. 2B ) . Leptin rose from basal concentrations ( Table 1 ) to 273 ± 78, 293 ± 12, and 391 ± 46 mg/l in ZO6, ZO9, and ZO12, respectively. Fig. 2C shows the evolution of hyperinsulinemia and increased HOMA-IR index, both peaking at 9 weeks. upregulated at the P < 0.01 level most primary metabolic processes and at P < 0.05 signal transduction, cell cycle, and mRNA transcription. In contrast, steroid metabolism and trans-sulfuration pathways, detoxifi cation, electron transport, induction of apoptosis,and mRNA transcription regulation were scored as downregulated ( Fig. 3C , left) . Transfer enzymes of one to three carbons, acyl fragments, phosphoryl groups, or electrons, and DNA binding proteins are primary targets of steatosis ( Fig. 3C , right) . Table 2 shows the list of 108 genes categorized by our own GO-based criterion. Two categories, metabolism and detoxifi cation, account for near 65% of the steatosis gene set. Genes with direct roles in lipid metabolism comprise 24% of the steatosis set and 36% of the upregulated group. Seventeen percent correspond to aerobic and anaerobic carbohydrate catabolism genes, all of which are upregulated. In contrast, steroid metabolism and detoxifi cation genes make up 47% of the set whose expression is suppressed in steatosis. Most cellular communication genes (70%) are upregulated, whereas the gene subsets for defense, cell growth, and proliferation, and protein synthesis and transformation are mostly (67-69%) downregulated.
Transcriptomic and functional metabolic dysregulation in hepatocytes from steatotic livers
All (>40) direct effectors of lipid and carbohydrate metabolism genes showed signifi cant increases in expression in steatotic hepatocytes. Critical genes for fatty acid uptake, de novo synthesis, activation and oxidation, as well as for glycerolipid synthesis were 2-to 7-fold upregulated compared with controls. These include Me1, G6pdx, and Acly, which provide NADPH and acetyl-CoA for lipogenesis, and Fasn, Elovl5, Scd1, and Scd2, which form mainly oleate and palmitoleate from saturated fatty acids, a conversion that facilitates the synthesis of storage lipids. Likewise, Cd36 that facilitates FA entry into hepatocytes showed a robust upregulation, while Lipc overexpression suggests effi cient lipolytic clearance of chylomicron remnants and intermediate-density lipoprotein TG at the liver endothelium. Essential genes that handle excessive fatty acids through glycerolipid synthesis (Gpam, Ppap2c, Arf1, and Dgat1), as well as the lipid droplet formation-linked adipophilin and spot 14, were upregulated, as were critical genes involved in mitochondrial and peroxisomal fatty acid oxidation (Acsl5, Crot, Cpt1a, and Acaa1). Interestingly, expression of transcriptional regulators sterol-regulatory element binding protein 1c (SREBP1c), hepatocyte nuclear factor 4 ␣ , peroxisome proliferator-activated receptor ␣ (PPAR ␣ ), and PPAR ␥ , however, were unaffected. In most cases, their mRNA levels in hepatocytes from lowgraded steatotic livers (ZO6, with 39 ± 4% of steatotic hepatocytes) did not differ signifi cantly from controls, while they increased sharply in hepatocytes from livers affected by severe steatosis (from 55 ± 6% to 76 ± 6% of steatotic hepatocytes) (see supplementary Table I ). Particularly, SREBP1c and PPAR ␥ transcript overexpression was documented in ob/ob and db/db mice ( 30 ) and in Zucker diabetic rats ( 31 ) , all at 10-12 weeks. Work by us using qPCR showed SREBP1c mRNA overexpression in hepatocytes from Zucker fa/fa rats of 12 weeks of age but not in cells from ZO6 or ZO9 rats (data not shown). Similar fi ndings were reported recently in 12 week old ob/ob mice and fa/ fa rat livers ( 32 ) , suggesting that the overexpression of SREBP1c mRNA is linked to late stages of steatosis in such murine models. Strain-and species-specifi c mechanisms seem to operate, moreover, in the PPAR ␥ mRNA expression regulation, given the lack of change found by us and by Oana et al. ( 33 ) in fa/fa rats of any age. Supplemental Material can be found at: Fig. 4 . Increased hepatic lipogenic activity and TG-rich VLDL production in obese Zucker rats. A: Glucose-6-phosphate dehydrogenase, malic enzyme, and ACC activity in hepatocytes of 6, 9, and 12 week old obese Zucker rats (ZO, closed bars) and their age-matched lean controls (ZL, open bars). B: Rats (9 weeks) were injected with 600 mg/kg Triton WR1339 or saline, blood samples were drawn before (0 h) and 2 h after injection, and lipoprotein isolated and assayed for TG and cholesterol (Ch). Lipoprotein sizing was performed in 0 h samples. Mean ± SD from four animals. * P < 0.05, ** P < 0.01, and *** P < 0.001.
Overexpression of genes required for fructose transport (Slc2a5), activation (Khk), and excision (Aldob); regulation of glycolysis (Pklr and Pfkfb1); and the pentose-phosphate pathway (G6pdx, Tkt, and Taldo1) were robust. Likewise, expression of two components of the pyruvate dehydrogenase complex, including the 70 kDa mitochondrial autoantigen, increased more than 2-fold. It is interesting to note that the enhanced conversion of pyruvate to acetyl-CoA within mitochondria not only supplies 2C fragments for lipogenic purposes but also for ATP production. Evaluation of glucose 6-phosphate dehydrogenase, malic enzyme, and ACC activity confi rmed that such upregulated lipogenic program was effectively translated into a higher fatty acid biosynthetic activity ( Fig. 4A ) , with increases of ‫ف‬ 4-5-fold over controls recorded in hepatocytes from ZO6 and ZO9 rats and to a lesser extent in ZO12 cells.
Genes relative to VLDL assembly and cholesterol homeostasis were minimally affected. Notwithstanding, more and larger TG-rich VLDL particles were secreted by the liver of 9 week old obese rats ( Fig. 4B ) . Estimation of the 2 h hepatic production of apolipoprotein B (apoB) and lipid in VLDL by in vivo Triton WR1339 studies revealed enhanced output of TGs by ‫ف‬ 3-fold and of cholesterol and apoB (mostly the edited form apoB48) by ‫ف‬ 60-100% in obese compared with lean rats. Further dynamic scattering and lipid analyses of lipoprotein particles after their chromatographic separation confi rmed the presence of large TG-rich VLDLs in the circulation ( Fig. 4C ) .
Nonmetabolic genes are markedly altered in hepatocytes from steatotic livers
Impaired detoxifi cation and mild oxidative stress may be envisaged from the number of related genes that are downregulated in steatotic hepatocytes. Of note is the low expression of the ammonia detoxifying Glul and of a substantial number of drug-metabolizing and cytochrome genes, although the oxidative stress marker Cyp2E1 is unaffected in early steatosis. Sult1c1 and Sult1c2, encoding phase II sulfotransferases, and Slco1a4, encoding the phase III transporter organic anion transporter 1a4, as well as Gnmt, a gene necessary for glutathione synthesis, were downregulated.
As expected, steatotic hepatocytes overexpressed several cell communication and defense genes, including the infl ammation-related Ptgis, the immunomodulatory Ctsb and Prlr, and acute-phase Orm1, Inhbe, and Hig1. 5 . Validation of microarray analysis by realtime qPCR. Expression of 11 genes was measured by qPCR in isolated hepatocytes of 6, 9, and 12 week old obese Zucker rats and their age-matched lean controls, using for normalization 18S rRNA and cyclophylin and GeNorm software. Mean ± SD from four animals. * P < 0.05, ** P < 0.01, and *** P < 0.001.
In contrast, expression of cadherin 17 (up to 8-fold decreased), which is involved in tissue structure and cellto-cell communication, was downregulated, giving a novel morphological clue for the high susceptibility of steatotic hepatocytes to injury. Some apoptosis and mitosis genes were upregulated, but others, such as c-Myc and Jun, were repressed.
The microarray data were validated by qPCR analysis of six steatosis-induced genes: Cd36, Me1, Fasn, Scd1, Acaa1, and Acsl5; two suppressed genes: Cdh17 and Egr1; and three unaffected genes: Cyp7a1, rate-limiting of bile acid synthesis; Prkaa2, the cell energy status sensor AMP kinase ␤ 1 catalytic subunit, and the transcription factor Ppara. Although the fold change for all genes differed slightly with respect to microarrays ( Table 2 ) , the patterns of change were similar ( Fig. 5 ) . Fasn was the most upregulated gene (up to 11-fold increased), while Cdh17 was most downregulated (up to 8-fold decreased).
Dysregulated genes in isolated hepatocytes correlated with the histological degree of hepatic steatosis
To determine whether the dysregulation of certain genes is associated with the hepatic steatosis in obese Zucker rats, we carried out a correlation analysis between changes in hepatocyte mRNA levels of genes quantifi ed by qPCR and the percentage of steatotic hepatocytes in each group of animals. We found that Fasn, Scd1, Cd36, and Me1 overexpression signifi cantly correlated with severity of hepatic steatosis (Fasn, r = 0.950, P < 0.001; Scd1, r = 0.867, P = 0.002; Cd36, r = 0.833, P = 0.005; Me1, r = 0.767, P = 0.015). No statistically signifi cant correlation was observed for Acaa1 and Acsl5 ( r = 0.477, P = 0.194; and r = 0.583, P = 0.099, respectively). Among downregulated genes, Cdh17, Cyp7a1, and Ppara (the two latter not steatosis-linked by microarrays), signifi cantly correlated with the percentage of steatotic hepatocytes (Cyp7a1, r = 0.867, P = 0.002; Cdh17, r = 0.695, P = 0.037; Ppara, r = 0.669, P = 0.048). No statistically signifi cant correlation was observed for Egr1 ( r = Ϫ 0.460, P = 0.213) and Prkaa2 ( r = 0.117, P = 0.765). The most signifi cant correlations are shown in Fig. 6 . It has been proposed that the N-terminal end of apoB acquires neutral lipid to form nucleation sites in the endoplasmic reticulum and that the number of these sites may be enhanced by increased TG synthesis ( 37 ) . In this model, an increased TG supply together with less TG recycling by hepatic IR may also lead to a rise in the number of lipidcontaining nucleation sites for the formation of larger TGrich VLDL particles. The hepatic overproduction of large TG-rich VLDLs ( Fig. 4 ) observed in obese Zucker rats strongly supports this concept and is in line with clinical reports showing overproduction of large VLDLs in human diabetes and obese insulin-resistant NAFLD patients ( 15 ) . There is recent animal data suggesting that hepatic steatosis may be protective in limiting the potential lipotoxicity associated with excessive NEFA output. Despite its plausibility, further studies are required as chronic steatosis increases the vulnerability of hepatocytes to a "second hit." In support of this, we have demonstrated dysregulation of genes relevant for cell survival (i.e., detoxifi cation, steroid metabolism, cell growth, and hepatic tissue structure genes) ( Figs. 3 and 7 ; Table 2 ). synthesis and secretion with hepatic IR; 3 ) signifi cant correlation of Fasn, Scd1, Cd36, and Me1 overexpression with severity of hepatic stetatosis; and 4 ) identifi cation of downregulated genes involved in maintaining tissue structure, detoxifi cation, and cell survival among steatotic hepatocytes (summarized in Fig. 7 ).
Major advances have been made in understanding the metabolic alterations leading to hepatic TG accumulation. It is well known that for VLDL synthesis, TG is mobilized from cytosolic lipid droplets by lipolysis followed by reesterifi cation of products by diacylglycerol acyltransferase-2, and some of the resulting product is transferred to nascent apoB during the assembly of primordial apoB-containing lipoproteins in the endoplasmic reticulum ( 34 ) . An alternative fate for a large proportion of the TG product is return to the cytosol in what appears to be a futile cycle that is enhanced by insulin and results in VLDL output suppression ( 34 ) and, thus, a major hepatic IR target. A distinct acyltransferase (Dgat1), modestly overexpressed herein, uses preferentially the serum NEFA pool (between 61 and 81% in the postprandial-fasting condition) for the formation of the cytosolic lipid droplet TGs ( 35 ) . Our results obtained from this murine model that resembles human obesity with IR phenotype ( 36 ) strongly support that fat accumulation in hepatocytes is a consequence of the upregu- cephalopathy due to liver failure ( 40 ) ]. Additional genes (such as Me1, Scd1, Acc, Fasn, Pdhb, and Cd36) have been previously associated with liver disease ( 41, 42 ) . Results in this study reinforce and extend such fi ndings as we demonstrate for the fi rst time that the overexpression of Me1, Cd36, Fasn, and Scd1 and the underexpression of Cdh17, Cyp7a1, and Ppara in primary hepatocytes signifi cantly correlated with the severity of hepatic steatosis in obese rats with IR ( Figs. 5 and 6 ), suggesting that dysregulation of these genes could play a central role in the pathogenesis of obesity-related fatty liver. The gene set associated with steatosis further includes genes encoding ligands, binding proteins, transporters, and proliferation and apoptosis regulators ( Table 2 ) . Alterations in these genes have also been identifi ed in individuals and animal models of NASH ( 43 ) , showing partial common gene signatures in human, mouse, and rat NAFLD.
In conclusion, we have identifi ed a set of 108 genes linked to chronic hepatic steatosis in primary hepatocytes in a model of obesity and IR. We fi nd that early activation of the complete lipogenic program, TG synthesis, and TG-rich VLDL export occurs in tandem with downregulation of tissue structure, steroid metabolism, detoxifi cation and cell growth, and proliferation genes, indicating that gene expression abnormalities in steatotic hepatocytes are Fat accumulation in the liver is associated with decreased effi ciency of the mitochondrial phosphorylative system ( 38 ) . When the cells become dependent on ATP, adenylate kinase turns into action to generate ATP and AMP, whose level rises. According to a canonical line of thinking, this is sensed by AMP kinase, which switches on the ATP-producing catabolic pathways and formation of malonyl-CoA by ACC is blocked. What we have learned from the fi ndings shown in Fig. 4 and Table 2 is that ACC is dysregulated and very active in steatotic hepatocytes and that the elevated demand of ATP for lipogenesis has to be met by glucose and fructose oxidation; the two routes appear to be transcriptionally favored. High consumption of fructose in the diet is known to cause hepatic steatosis by upregulation of lipogenic SREBPlc expression ( 39 ) . A striking and novel observation is that in obesity-related hepatic steatosis, hepatocytes are predisposed for fructose uptake and oxidation in the absence of any other dietary stimuli but calorie overconsumption.
Numerous novel, steatosis-linked genes have been identifi ed. These include Dio1 [encoding deiodinase, a selenoprotein that is downregulated in hypothyroidism, a phenotype that has been reported in patients with NASH ( 8, 36 ) ] and Bzrp [encoding the peripheral-type benzodiazepine receptor that has been associated with hepatic en- Fig. 7 . In response to chronic excess nutrient supply and insulin resistance, hepatocytes become steatotic and vulnerable to various insults. A: Metabolic pathways and genes contributing to FA supply and TG accumulation in primary hepatocytes. In red: processes that are activated by microarray or functional analyses and genes whose overexpression correlates positively with steatosis severity. More than 40 direct effectors of lipid and carbohydrate metabolism genes showed signifi cant increases in expression in steatotic hepatocytes. B: Deregulation of a panel of defense and survival genes are associated with simple steatosis. In green: genes whose repression correlates positively with steatosis severity. The unigene title for each gene is given in Table 2 . not confi ned to lipid metabolism genes ( Fig. 7 ) . Further functional studies on the role of some of these steatosislinked genes should lead to a better understanding of the early pathogenic mechanisms of hepatic steatosis and its susceptibility to liver cell damage as well as to identify molecular targets with potential therapeutic utility to modify the outcome of obesity-related fatty liver.
